IGH/MALT1 Fusion, t(14;18)(q32;q21), FISH Print

WSLH Department: Cytogenetics
WSLH Test Code: 881F68
Day(s) Performed: Monday-Friday 7:45 AM - 4:30 PM, Saturday 7:45 AM - 12:00 PM
Turn-around Time: Approximately 4-6 days. (Reports are issued Monday-Friday 7:45 AM - 4:30 PM)
Recommended Uses: Detection of the IGH/MALT1 fusion associated with lymphoma of mucosa associated lymphoid tissue and other B-cell lymphomas such as DLBCL. Aids in diagnosis and prognosis of hematologic disorders and for monitoring disease after treatment or bone marrow transplant. May be performed in conjunction with other FISH assays, chromosome analysis or as an independent test.
Contraindications:
Additional Tests Performed:
Patient Preparations:
Specimen Requirements: Bone marrow: 0.5-1.0 ml early aspirate bone marrow collected in sodium heparin. OR Blood: 1-2 ml whole blood collected in sodium heparin vacuum type tube. OR Fresh tissue: At least 0.3cm cubed section of tumor; avoid areas of necrosis
Specimen Handling & Transport: Store and transport specimens at room temperature (may transport with coolant during hot weather, >85 degrees F). DO NOT FREEZE. The laboratory must receive specimens within 24 to 48 hours of collection.
Collection Kit/Container:
Collection Instructions: ** Bone marrow: 0.5-1.0 ml bone marrow from the 1st or 2nd aspirate. Material submitted for cytogenetic analysis must be from an early aspirate to avoid dilution with blood. Rinse the syringe to be used for aspiration by drawing sodium heparin solution (1000 USP units/ml) into the syringe and then expelling all the heparin solution (over-heparinization is toxic to the cells). Transfer the marrow to a sterile, sodium heparin vacuum type tube for delivery to State Lab. If an aspirate is unsuccessful, a 10mm bone core biopsy may be submitted in a sterile transport medium with sodium.

**Heparin. Draw blood using aseptic techniques into a sterile sodium heparin vacuum type tube. Invert tube to mix. If using larger tubes, draw full tube of blood to avoid over-treatment with anti-coagulant.

**Fresh tissue: A 0.3-1.0cm cubed section collected using aseptic procedures; avoid areas of necrosis. Place the specimen in a sterile tissue vial containing transport media.
Unacceptable Conditions: Bone marrow/blood that is clotted or hemolyzed is not acceptable. Bone marrow/blood must not be frozen. Plasma and serum are not acceptable. Samples must not be frozen.
Requisition Form: Cytogenetics Lab Neoplasia Diagnosis Form #132
Required Information: Laboratory regulations require the following minimum information to be provided on the requisition form for a specimen to be accepted for testing: Patient name or unique identifier; date and time of collection, patient date of birth and sex, specimen type/site of collection, test request(s), reason for referral, clinician name and UPIN/NPI, and address for reporting results. Please be certain that name/identifier on the form matches that on the specimen label.
Results Include: Number of nuclei examined, percent positive for fusion, and the reference range for false positives based on the number of cells with an abnormal signal pattern in 200 control cells. Result written using current International System for Human Cytogenetic Nomenclature (ISCN) and interpretation of results.
Limitations: Failure to identify an abnormal clone by FISH does not rule out the presence of other abnormalities in the specimen.
Additional Tests Recommended:
Additional Comments: If FISH assay is not performed in conjunction with chromosome analysis there is an additional charge for processing the specimen.
Methodology: Fluorescence in situ hybridization performed on interphase nuclei using dual fusion DNA probes (LSI IGH/MALT1 dual color, dual fusion; Abbott Molecular) specific for the IGH gene in 14q32 and the MALT1 gene in 18q21.
Includes: FISH analysis of 200 interphase cells for fusion of the IGH and MALT1 genes
CPT Code: 88271x2, 88275
Price: For pricing information, please call 608-262-0402.
Back to test list